应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02315 百奥赛图-B
已收盘 08-14 16:08:36
69.000
-1.250
-1.78%
最高
71.500
最低
67.950
成交量
110.82万
今开
70.250
昨收
70.250
日振幅
5.05%
总市值
308.43亿
流通市值
76.59亿
总股本
4.47亿
成交额
7,691万
换手率
1.00%
流通股本
1.11亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
异动解读|百奥赛图-B盘中上涨5.07%,上半年归母净利润最高预增超4倍叠加机构持续增持
行情直击 · 08-13 13:28
异动解读|百奥赛图-B盘中上涨5.07%,上半年归母净利润最高预增超4倍叠加机构持续增持
异动解读|百奥赛图-B盘中上涨5.68%,上半年归母净利润最高预增超4倍叠加机构持续增持
行情直击 · 08-11
异动解读|百奥赛图-B盘中上涨5.68%,上半年归母净利润最高预增超4倍叠加机构持续增持
AI医疗概念股普升 剂泰科技-P(07666)涨12.86%、晶泰控股(02228)涨10.26%
金吾财讯 · 08-10
AI医疗概念股普升 剂泰科技-P(07666)涨12.86%、晶泰控股(02228)涨10.26%
异动解读|百奥赛图-B盘中上涨5.1%,上半年归母净利润最高预增超4倍叠加机构持续增持
行情直击 · 08-10
异动解读|百奥赛图-B盘中上涨5.1%,上半年归母净利润最高预增超4倍叠加机构持续增持
百奥赛图-B(02315.HK)获易方达基金增持18.8万股
中金财经 · 08-07
百奥赛图-B(02315.HK)获易方达基金增持18.8万股
百奥赛图-B:易方达基金管理有限公司增持,好仓比例升至10.0%
港股披露 · 08-07
百奥赛图-B:易方达基金管理有限公司增持,好仓比例升至10.0%
异动解读|百奥赛图-B盘中上涨9.45%,上半年归母净利润预增最高超4倍
行情直击 · 08-07
异动解读|百奥赛图-B盘中上涨9.45%,上半年归母净利润预增最高超4倍
港股午评|恒生指数早盘涨0.15% 国产大模型领涨科技板块
智通财经 · 08-07
港股午评|恒生指数早盘涨0.15% 国产大模型领涨科技板块
百奥赛图-B盘中涨超7% 上半年归母净利润最高预增超4倍
新浪港股 · 08-07
百奥赛图-B盘中涨超7% 上半年归母净利润最高预增超4倍
港股异动 | 百奥赛图-B(02315.HK)涨近6% 上半年归母净利最高预增超4倍 两大业务线实现双轮驱动
智通财经 · 08-07
港股异动 | 百奥赛图-B(02315.HK)涨近6% 上半年归母净利最高预增超4倍 两大业务线实现双轮驱动
百奥赛图-B(02315.HK)2026年半年度业绩预增公告:营收保持高速增长,规模化盈利加速释放
智通财经 · 08-06
百奥赛图-B(02315.HK)2026年半年度业绩预增公告:营收保持高速增长,规模化盈利加速释放
百奥赛图-B(02315.HK)发盈喜 预计上半年归母净利润2.36亿至2.46亿元 同比增加391.87%至412.71%
智通财经 · 08-06
百奥赛图-B(02315.HK)发盈喜 预计上半年归母净利润2.36亿至2.46亿元 同比增加391.87%至412.71%
百奥赛图-B(02315)公布2026年中期业绩预告:归母净利最高约2.46亿元,同比增逾4.1倍
公告速递 · 08-06
百奥赛图-B(02315)公布2026年中期业绩预告:归母净利最高约2.46亿元,同比增逾4.1倍
百奥赛图-B7月股份变动月报表披露,股本维持不变
公告速递 · 08-05
百奥赛图-B7月股份变动月报表披露,股本维持不变
易方达基金增持百奥赛图(02315.HK)18.8万股 每股作价约51.96港元
智通财经 · 08-04
易方达基金增持百奥赛图(02315.HK)18.8万股 每股作价约51.96港元
港股异动 | 百奥赛图-B(02315)涨超10% 双抗ADC推进海外开发 临床前CRO与模型鼠景气度上行
智通财经 · 08-04
港股异动 | 百奥赛图-B(02315)涨超10% 双抗ADC推进海外开发 临床前CRO与模型鼠景气度上行
异动解读|百奥赛图-B盘中上涨5.43%,与Whitehawk达成双抗ADC全球战略合作
行情直击 · 08-04
异动解读|百奥赛图-B盘中上涨5.43%,与Whitehawk达成双抗ADC全球战略合作
港股异动 | 百奥赛图-B(02315)午后涨超8% 近期与Whitehawk达成合作 旗下5款双抗ADC出海
智通财经网 · 08-03
港股异动 | 百奥赛图-B(02315)午后涨超8% 近期与Whitehawk达成合作 旗下5款双抗ADC出海
富国基金增持百奥赛图(02315)55.65万股 每股作价约51.81港元
智通财经 · 07-31
富国基金增持百奥赛图(02315)55.65万股 每股作价约51.81港元
百奥赛图-B:富国基金管理有限公司增持,好仓比例升至8.23%
港股披露 · 07-31
百奥赛图-B:富国基金管理有限公司增持,好仓比例升至8.23%
加载更多
公司概况
公司名称:
百奥赛图-B
所属市场:
SEHK
上市日期:
--
主营业务:
百奥赛图(北京)医药科技股份有限公司是一家主要基于自主开发的基因编辑技术提供各类创新模式动物以及临床前阶段的医药研发服务的中国公司。该公司利用其自主开发的“RenMice”全人源抗体和T细胞受体(TCR)小鼠平台针对人体内潜在药物靶点进行规模化药物发现与开发。该公司主要业务包括创新模式动物销售、临床前药理药效评价服务及抗体开发。该公司还提供基因编辑服务。该公司在中国国内市场及海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02315","market":"HK","secType":"STK","nameCN":"百奥赛图-B","latestPrice":69,"timestamp":1786694916006,"preClose":70.25,"halted":0,"volume":1108210,"delay":0,"changeRate":-0.017793594306049824,"floatShares":111000000,"shares":447000000,"eps":0.43,"marketStatus":"已收盘","change":-1.25,"latestTime":"08-14 16:08:36","open":70.25,"high":71.5,"low":67.95,"amount":76905749,"amplitude":0.050534,"askPrice":69,"askSize":9000,"bidPrice":68.7,"bidSize":500,"shortable":3,"etf":0,"ttmEps":0.736,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786930200000},"marketStatusCode":5,"adr":0,"listingDate":1661961600000,"exchange":"SEHK","adjPreClose":70.25,"openAndCloseTimeList":[[1786671000000,1786680000000],[1786683600000,1786694400000]],"volumeRatio":0.300952,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688796","market":"SH","secType":"STK","nameCN":"百奥赛图","latestPrice":148.37,"timestamp":1786690800000,"preClose":148.2,"halted":0,"volume":3240000,"delay":0,"premium":"-60.04"}},"requestUrl":"/m/hq/s/02315","defaultTab":"news","newsList":[{"id":"1132627557","title":"异动解读|百奥赛图-B盘中上涨5.07%,上半年归母净利润最高预增超4倍叠加机构持续增持","url":"https://stock-news.laohu8.com/highlight/detail?id=1132627557","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132627557?lang=zh_cn&edition=full","pubTime":"2026-08-13 13:28","pubTimestamp":1786598925,"startTime":"0","endTime":"0","summary":"8月13日,百奥赛图-B盘中上涨5.07%,报70.5港元,成交额1.6亿港元。消息面上,公司此前发布业绩预告,预计上半年实现营业收入9.36亿至9.46亿元,同比增长51%至52%;归母净利润2.36亿至2.46亿元,同比增长392%至413%。此外,易方达基金持续增持公司股份,好仓比例已升至10.0%;富国基金持股比例亦升至8.23%,机构资金持续流入。公司此前与Whitehawk Therapeutics达成全球双抗ADC战略合作,模式动物与抗体开发双轮驱动,规模化盈利加速释放。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131233928","title":"异动解读|百奥赛图-B盘中上涨5.68%,上半年归母净利润最高预增超4倍叠加机构持续增持","url":"https://stock-news.laohu8.com/highlight/detail?id=1131233928","media":"行情直击","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1131233928?lang=zh_cn&edition=full","pubTime":"2026-08-11 10:37","pubTimestamp":1786415841,"startTime":"0","endTime":"0","summary":"8月11日,百奥赛图-B盘中上涨5.68%,报72.55港元,成交额6893.85万港元。消息面上,公司近日发布业绩预告,预计上半年实现营业收入9.36亿至9.46亿元,同比增长51%至52%;归母净利润2.36亿至2.46亿元,同比增长392%至413%。此外,易方达基金持续增持公司股份,好仓比例已升至10.0%;富国基金持股比例亦升至8.23%,机构资金持续流入。公司此前与Whitehawk Therapeutics达成全球双抗ADC战略合作,模式动物与抗体开发双轮驱动,规模化盈利加速释放。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658097936","title":"AI医疗概念股普升 剂泰科技-P(07666)涨12.86%、晶泰控股(02228)涨10.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658097936","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658097936?lang=zh_cn&edition=full","pubTime":"2026-08-10 10:03","pubTimestamp":1786327392,"startTime":"0","endTime":"0","summary":"金吾财讯 | AI医疗概念股盘初普升,截至发稿,剂泰科技-P 涨12.86%,晶泰控股涨10.26%,英硅智能涨9.38%,百奥赛图-B涨8.33%,讯飞医疗科技涨4.98%,医渡科技涨4.00%,云知声涨3.96%,平安好医生涨3.58%,阿里健康涨3.21%,京东健康涨2.98%。AIDD有望重塑早期药物发现的流程,大大加速早期药物筛选的效率及成功率,相关干实验投入的增加以及对湿实验需求持续的增长,有望为下游产业链持续带来增量。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/NDQ1MWJhN2NhODAzMzgwYTAyY2UxMDMzODA5NjE3NDc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NDQ1MWJhN2NhODAzMzgwYTAyY2UxMDMzODA5NjE3NDc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987779","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1109","BK1189","09678","AIPO","CHAT","BK1584","ARTY","VTHR","02315","00241","BK1141","BK1247","AGIX","01833","BK1502","HK0000165453.HKD","86618","BK1615","LU0051755006.USD","BK1142","BK1219","159891","02506","03696","BK1589","BK1610","BK1591","02228","LU0456827905.SGD","QTOC","BK1583","SGXZ62798434.SGD","BK1518","BK1571","BK1617","BK1515","BK1161","06618","BK1501","SGXZ86797644.SGD","07666","02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176592899","title":"异动解读|百奥赛图-B盘中上涨5.1%,上半年归母净利润最高预增超4倍叠加机构持续增持","url":"https://stock-news.laohu8.com/highlight/detail?id=1176592899","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176592899?lang=zh_cn&edition=full","pubTime":"2026-08-10 09:36","pubTimestamp":1786325802,"startTime":"0","endTime":"0","summary":"8月10日,百奥赛图-B盘中上涨5.1%,报65.05港元,成交额2745.71万港元。消息面上,公司近日发布业绩预告,预计上半年实现营业收入9.36亿至9.46亿元,同比增长51%至52%;归母净利润2.36亿至2.46亿元,同比增长392%至413%。此外,易方达基金持续增持公司股份,好仓比例已升至10.0%;富国基金同期亦多次增持,持股比例升至8.23%,机构资金持续流入彰显对公司成长性的认可。公司模式动物与抗体开发双轮驱动,叠加与Whitehawk达成全球双抗ADC战略合作,规模化盈利加速释放。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657642867","title":"百奥赛图-B(02315.HK)获易方达基金增持18.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2657642867","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657642867?lang=zh_cn&edition=full","pubTime":"2026-08-07 22:37","pubTimestamp":1786113422,"startTime":"0","endTime":"0","summary":"格隆汇8月4日丨根据联交所最新权益披露资料显示,2026年7月29日,百奥赛图-B(02315.HK)获易方达基金管理有限公司在场内以每股均价51.9633港元增持18.8万股,涉资约976.91万港元。\r\n\r\n 增持后,易方达基金管理有限公司最新持股数目为1013.2万股,持股比例由8.98%上升至9.15%。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202608/07/20260807870072.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202608/07/20260807870072.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260807/32329129.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","02315","BK0216","688796"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118309880","title":"百奥赛图-B:易方达基金管理有限公司增持,好仓比例升至10.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=1118309880","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118309880?lang=zh_cn&edition=full","pubTime":"2026-08-07 17:12","pubTimestamp":1786093955,"startTime":"0","endTime":"0","summary":"易方达基金管理有限公司于2026年8月3日以每股均价52.6105港元买入百奥赛图-B(02315)股份3.10万股,涉资约163.09万港元。易方达基金管理有限公司此次增持前持有百奥赛图-B好仓1105.15万股,占比9.98%;增持后持股量为1108.25万股,好仓比例升至10.0%。原文链接:Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115699575","title":"异动解读|百奥赛图-B盘中上涨9.45%,上半年归母净利润预增最高超4倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1115699575","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115699575?lang=zh_cn&edition=full","pubTime":"2026-08-07 15:04","pubTimestamp":1786086290,"startTime":"0","endTime":"0","summary":"8月7日,百奥赛图-B盘中上涨9.45%,报60.8港元,成交额1.68亿港元。消息面上,公司发布业绩预告,预计上半年实现营业收入9.36亿元至9.46亿元,同比增长51%至52%;归属于母公司所有者的净利润为2.36亿元至2.46亿元,同比增长392%至413%,上年同期归母净利润约4800万元。此前一季度公司已实现归母净利润1.04亿元,同比扭亏为盈。公司模式动物与抗体开发两大业务线实现双轮驱动,截至去年底已累计签署超350项药物合作开发及授权协议,规模化盈利加速释放。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"百奥赛图-B盘中上涨9.45%,上半年归母净利润预增最高超4倍","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657695468","title":"港股午评|恒生指数早盘涨0.15% 国产大模型领涨科技板块","url":"https://stock-news.laohu8.com/highlight/detail?id=2657695468","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657695468?lang=zh_cn&edition=full","pubTime":"2026-08-07 12:00","pubTimestamp":1786075220,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,港股恒生指数涨0.15%,涨37点,报25567点;恒生科技指数涨0.34%。港股早盘成交1412亿港元。国产大模型再度领涨科技板块。MINIMAX-W再涨17.7%,入通首日北水抢筹近27亿港元,ARR呈现阶梯式跳升;智谱涨超17.57% AI模型竞争转向综合比拼,机构看好公司商业化爆发潜力。海清智元再涨超7%,大模型摆脱高性能服务器依赖,降低客户部署成本。新特能源涨10%;协鑫科技涨7.46%。万洲国际跌3.65%,董事会会议延期至8月28日审议中期业绩。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477175.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1554","HSI","SG9999001051.SGD","07300","09115","SG9999001226.SGD","BK1163","03115","00656","BK1237","LU0173614495.USD","LU0702159699.USD","00288","BK1535","LU0359201612.USD","LU1166156734.SGD","03033","02315","513600","LU0300738605.USD","PCFBY","FOSUY","82800","HHImain","02837","BK1117","BK1225","03800","LU0314109678.HKD","07500","00100","LU0541502299.USD","LU1235295612.USD","BK1169","00975","02513","01392","03986","03088","06628","LU0593848301.USD","LU1328277881.USD","02833","SGXZ90724238.SGD","BK1161","MCHmain","LU0708995583.HKD","HK0000252160.HKD","SG9999001069.SGD","83115","03037","SG9999001093.SGD","LU0300738514.USD","09067","LU1813983027.USD","HSTECH","BK1172","03423","09088","BK1179","LU0541501648.USD","BK1103","BK1610","LU0052750758.USD","WHGLY","LU0359201885.HKD","LU0274383008.USD","SG9999011746.SGD","BK1538","02800","SG9999003461.SGD","LU0287142896.SGD","HK0000252152.HKD","HK0000500386.USD","LU1046422090.SGD","07226","SG9999014674.SGD","LU2039709279.SGD","603986","03419","03032","07200","BK1230","LU0049112450.USD","03417","LU0390135688.USD","01799","SG9999002950.SGD","BK1603","LU0390135332.USD","LU0320764599.SGD","LU0359202008.SGD","688796","BK1148","BK1594","LU1023057109.AUD","BK1521","02343","03067","02282","LU0390135506.SGD","07552","MCHVY","BK1543"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657939816","title":"百奥赛图-B盘中涨超7% 上半年归母净利润最高预增超4倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2657939816","media":"新浪港股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657939816?lang=zh_cn&edition=full","pubTime":"2026-08-07 11:16","pubTimestamp":1786072560,"startTime":"0","endTime":"0","summary":"模拟交易客户端百奥赛图-B盘中涨超7%,截至发稿,涨幅回落至小涨3.06%,现报57.25港元,成交额8062.83万港元。百奥赛图发布公告称,预计2026年半年度实现营业收入9.36亿元至9.46亿元,同比增长50.80%-52.41%;归属于母公司所有者的净利润为2.36亿元至2.46亿元,同比增长392%-413%。截至2025年12月31日,百奥赛图已累计签署超过350项药物合作开发/授权/转让协议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-08-07/doc-inimneni4164154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02315","688796"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657698311","title":"港股异动 | 百奥赛图-B(02315.HK)涨近6% 上半年归母净利最高预增超4倍 两大业务线实现双轮驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2657698311","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657698311?lang=zh_cn&edition=full","pubTime":"2026-08-07 10:25","pubTimestamp":1786069545,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657368900","title":"百奥赛图-B(02315.HK)2026年半年度业绩预增公告:营收保持高速增长,规模化盈利加速释放","url":"https://stock-news.laohu8.com/highlight/detail?id=2657368900","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657368900?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:24","pubTimestamp":1786008269,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657593686","title":"百奥赛图-B(02315.HK)发盈喜 预计上半年归母净利润2.36亿至2.46亿元 同比增加391.87%至412.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657593686","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657593686?lang=zh_cn&edition=full","pubTime":"2026-08-06 16:36","pubTimestamp":1786005416,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02315","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118488692","title":"百奥赛图-B(02315)公布2026年中期业绩预告:归母净利最高约2.46亿元,同比增逾4.1倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1118488692","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118488692?lang=zh_cn&edition=full","pubTime":"2026-08-06 16:36","pubTimestamp":1786005410,"startTime":"0","endTime":"0","summary":"2026年8月6日,百奥赛图-B发布内幕消息,披露截至2026年6月30日止六个月的未经审计业绩预告。公司预计,本期实现营业收入93,638.86万元至94,638.86万元,同比增加31,542.54万元至32,542.54万元,增幅50.80%至52.41%。预计归属于母公司所有者的净利润为23,609.44万元至24,609.44万元,同比增加18,809.53万元至19,809.53万元,增幅391.87%至412.71%。上年同期,公司营业收入为62,096.32万元;归属于母公司所有者的净利润为4,799.91万元;扣非后归母净利润为2,855.21万元;每股收益为0.12元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125963329","title":"百奥赛图-B7月股份变动月报表披露,股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1125963329","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125963329?lang=zh_cn&edition=full","pubTime":"2026-08-05 10:05","pubTimestamp":1785895540,"startTime":"0","endTime":"0","summary":"百奥赛图(北京)医药科技股份有限公司于2026年8月5日发布截至2026年7月31日的股份变动月报表。报告期内,公司股本结构保持稳定,无新增发行、购回、注销或库藏股变动。百奥赛图-B本月H股已发行股份数量为110,781,920股,与上月持平,不存在库藏股;A股已发行股份数量为336,116,500股,同样维持不变。上述数据表明,报告期内公司并无新的股份增发或变化。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656558025","title":"易方达基金增持百奥赛图(02315.HK)18.8万股 每股作价约51.96港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2656558025","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656558025?lang=zh_cn&edition=full","pubTime":"2026-08-04 19:29","pubTimestamp":1785842949,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656538672","title":"港股异动 | 百奥赛图-B(02315)涨超10% 双抗ADC推进海外开发 临床前CRO与模型鼠景气度上行","url":"https://stock-news.laohu8.com/highlight/detail?id=2656538672","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656538672?lang=zh_cn&edition=full","pubTime":"2026-08-04 15:00","pubTimestamp":1785826839,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,百奥赛图-B涨超10%,截至发稿,涨10.39%,报57.9港元,成交额8028.46万港元。消息面上,百奥赛图上月宣布与Whitehawk Therapeutics, Inc.签署一项全球战略合作协议,涵盖多个双特异性抗体偶联药物研发项目,双方将共同推进多元化的新一代治疗产品管线。据悉,从双方正式启动合作到完成协议签署,历时仅仅约四个月。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475697.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02315","NETL","BK4080","BK4588","KCAI","ADC","BK4585","688796","VXUS","BK0216","BK4231","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102288399","title":"异动解读|百奥赛图-B盘中上涨5.43%,与Whitehawk达成双抗ADC全球战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1102288399","media":"行情直击","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102288399?lang=zh_cn&edition=full","pubTime":"2026-08-04 09:39","pubTimestamp":1785807549,"startTime":"0","endTime":"0","summary":"8月4日,百奥赛图-B盘中上涨5.43%,报55.55港元,成交额631.34万港元。消息面上,公司近日与Whitehawk Therapeutics达成全球战略合作协议,百奥赛图将通过自主研发的RenLite平台提供五款全人双特异性抗体,Whitehawk将结合其ADC连接子-载荷平台技术进行评估,并有权将由此产生的BsADC候选分子纳入管线推进开发。百奥赛图将获得首付款及潜在里程碑付款。此外,近期富国基金、易方达基金连续增持公司股份,富国基金最新持股比例升至8.23%,机构资金持续流入提振市场信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656432314","title":"港股异动 | 百奥赛图-B(02315)午后涨超8% 近期与Whitehawk达成合作 旗下5款双抗ADC出海","url":"https://stock-news.laohu8.com/highlight/detail?id=2656432314","media":"智通财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656432314?lang=zh_cn&edition=full","pubTime":"2026-08-03 14:28","pubTimestamp":1785738520,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,百奥赛图-B午后涨超8%,截至发稿,涨6.28%,报53.3港元,成交额5248.07万港元。消息面上,近日,百奥赛图与Whitehawk Therapeutics达成一项全球战略合作协议,涵盖多个双特异性抗体偶联药物研发项目,双方将共同推进新一代治疗产品管线。据悉,Whitehawk将对百奥赛图提供的五款双特异性抗体进行评估,并有权选择将任何由此产生的ADC候选药物推进至其研发管线中,百奥赛图将获得一定数额的首付款及潜在里程碑付款。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475186.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1161","ADC","688796","NETL","BK4588","BK4231","KCAI","02315","BK0216","BK4585","VXUS","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655104363","title":"富国基金增持百奥赛图(02315)55.65万股 每股作价约51.81港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2655104363","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655104363?lang=zh_cn&edition=full","pubTime":"2026-07-31 19:14","pubTimestamp":1785496474,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新数据显示,7月29日,富国基金增持百奥赛图(02315)55.65万股,每股作价51.8055港元,总金额约为2882.98万港元。增持后最新持股数目约为911.60万股,持股比例为8.23%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1474778.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","EWH","688796","BK0216","02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118973322","title":"百奥赛图-B:富国基金管理有限公司增持,好仓比例升至8.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=1118973322","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118973322?lang=zh_cn&edition=full","pubTime":"2026-07-31 17:12","pubTimestamp":1785489121,"startTime":"0","endTime":"0","summary":"富国基金管理有限公司于2026年7月29日以每股均价51.8055港元买入百奥赛图-B股份55.65万股,涉资约2882.98万港元。富国基金管理有限公司此次增持前持有百奥赛图-B好仓855.95万股,占比7.73%;增持后持股量为911.60万股,好仓比例升至8.23%。原文链接:Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bbctg.com.cn","stockEarnings":[{"period":"1week","weight":0.2646},{"period":"1month","weight":0.3305},{"period":"3month","weight":0.3748},{"period":"6month","weight":0.3131},{"period":"1year","weight":1.8372},{"period":"ytd","weight":0.9901}],"compareEarnings":[{"period":"1week","weight":-0.0052},{"period":"1month","weight":0.0434},{"period":"3month","weight":-0.0218},{"period":"6month","weight":-0.0441},{"period":"1year","weight":-0.0085},{"period":"ytd","weight":-0.0091}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"百奥赛图(北京)医药科技股份有限公司是一家主要基于自主开发的基因编辑技术提供各类创新模式动物以及临床前阶段的医药研发服务的中国公司。该公司利用其自主开发的“RenMice”全人源抗体和T细胞受体(TCR)小鼠平台针对人体内潜在药物靶点进行规模化药物发现与开发。该公司主要业务包括创新模式动物销售、临床前药理药效评价服务及抗体开发。该公司还提供基因编辑服务。该公司在中国国内市场及海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.018702},{"month":2,"riseRate":0.75,"avgChangeRate":0.087225},{"month":3,"riseRate":0.5,"avgChangeRate":0.15364},{"month":4,"riseRate":0.25,"avgChangeRate":-0.063264},{"month":5,"riseRate":0.5,"avgChangeRate":0.097922},{"month":6,"riseRate":0.25,"avgChangeRate":-0.005144},{"month":7,"riseRate":0.5,"avgChangeRate":-0.006831},{"month":8,"riseRate":0.5,"avgChangeRate":0.058218},{"month":9,"riseRate":0.666667,"avgChangeRate":0.092895},{"month":10,"riseRate":0.25,"avgChangeRate":-0.096483},{"month":11,"riseRate":0.5,"avgChangeRate":0.009059},{"month":12,"riseRate":0.5,"avgChangeRate":0.137663}],"exchange":"SEHK","name":"百奥赛图-B","nameEN":"BIOCYTOGEN-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百奥赛图-B(02315)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百奥赛图-B,02315,百奥赛图-B股票,百奥赛图-B股票老虎,百奥赛图-B股票老虎国际,百奥赛图-B行情,百奥赛图-B股票行情,百奥赛图-B股价,百奥赛图-B股市,百奥赛图-B股票价格,百奥赛图-B股票交易,百奥赛图-B股票购买,百奥赛图-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百奥赛图-B(02315)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}